comparemela.com

Latest Breaking News On - Ferring pharmaceuticals - Page 5 : comparemela.com

Nadofaragene Firadenovec Demonstrates Durable 5-Year Activity in NMIBC

Nadofaragene firadenovec led to durable antitumor activity in BCG-unresponsive NMIBC either with CIS or papillary disease, according to 5-year data from the phase 3 Study CS-003.

CG follows big IPO with new results for bladder cancer drug

How To Choose Participants For Your Emerging Leader Program

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.